Mabwell(SH:688062) Jin Rong Jie·2025-08-12 14:15Group 1 - The stock price of Maiwei Biotech-U is reported at 33.09 yuan, down by 0.71 yuan from the previous trading day, with a trading volume of 4.27 billion yuan [1] - Maiwei Biotech-U operates in the biopharmaceutical industry, focusing on the research, production, and sales of antibody drugs, including monoclonal antibodies and bispecific antibody drugs [1] - The company announced the completion of the first patient dosing in the clinical trial of its innovative drug 9MW2821 targeting Nectin-4ADC for patients with ADC-treated triple-negative breast cancer in the United States, marking its first overseas clinical trial [1] Group 2 - On August 12, the net outflow of main funds was 46.4564 million yuan, with a cumulative net outflow of 218 million yuan over the past five days [1]